other material
confidence high
sentiment neutral
materiality 0.35
Nu-Med Plus raises $450,000 selling 171,232 Series A Preferred at $2.628; conversion equals 3.42M common
Nu-Med Plus, Inc.
- Two accredited investors bought 171,232 shares of Series A Preferred at $2.628 per share for aggregate proceeds of $450,000 on Oct 19, 2026.
- Investors got piggy-back registration rights to include conversion shares in any resale registration statement the company files within two years.
- Full conversion of the investors' preferred would yield 3,424,640 common shares; a consultant's 50,000 preferred converts into 1,000,000 common shares.
- The company issued the consultant 50,000 Series A Preferred for services rendered and paid no sales commissions on any of the sales.
- Offering is best-efforts with no minimum, capped at 190,258 shares or $500,000, ending Oct 30, 2026 unless the board extends up to 90 days.